HRS 2016 ROUND-UP: Medtronic Unveils New “Extravascular ICD”
The 2016 Heart Rhythm Society’s Annual Scientific Sessions were held in San Francisco on May 4-7 and featured over 250 educational sessions on cardiac rhythm management and electrophysiology, including presentations of new clinical data from medical device trials. Here are some of the highlights.
You may also be interested in...
In a 21-patient first in-human pilot trial, Medtronic’s Extravascular Implantable Cardioverter Defibrillator (EV ICD) system successfully terminated induced ventricular arrhythmias in 89.5% of patients and achieved pacing capture in 95% of patients.
HRS 2018 Wrap-Up: Tendril Lead Failures; Metaanalysis Of Contact-Force Catheter; LuxCath's OmniView; More Micra Results
The 2018 Heart Rhythm Society scientific sessions in Boston covered a variety of presentations of new electrophysiology clinical data, including a report on the failure of St. Jude's Tendril leads, a meta-analysis of contact-force catheters for atrial-fibrillation ablation, and new data on Medtronic's Micra leadless pacemaker.
Boston Scientific cardiac rhythm management has been struggling to compete with MRI-compatible devices from rival Medtronic.